FourWorld Capital Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

FourWorld Capital Management’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Buy	499,196 +116,496	+30%	+$357K	0.78%	17
2025 Q4	$1.36M	Buy	382,700 +24,700	+7%	+$91.6K	1.1%	14
2025 Q3	$1.25M	Sell	358,000 -33,650	-9%	-$115K	1.97%	13
2025 Q2	$803K	Buy	391,650 +134,650	+52%	+$337K	0.54%	16
2025 Q1	$293K	Hold	257,000	–	–	0.19%	19
2024 Q4	$79.4K	Hold	257,000	–	–	0.04%	19
2024 Q3	$84K	Hold	257,000	–	–	0.05%	24
2024 Q2	$118K	Buy	257,000 +6,641	+3%	+$5.67K	0.07%	24
2024 Q1	$396K	Buy	+250,359	New	+$476K	0.25%	25

Other funds holding STLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FourWorld Capital Management's STLN Position: Q1 2026 in Review

FourWorld Capital Management increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 30% in Q1 2026, buying an estimated $357K and bringing the position to 499,196 shares worth $1.53M. The position accounts for 0.78% of the portfolio, ranked #17.

FourWorld Capital Management first reported a position in STLN in Q1 2024 and has held it in 9 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

FourWorld Capital Management held 499,196 shares of Starling Oncology Institute, Inc. Common Stock worth $1.53M as of Q1 2026.
FourWorld Capital Management bought 116,496 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $357K.
Starling Oncology Institute, Inc. Common Stock made up 0.78% of FourWorld Capital Management's portfolio in Q1 2026, its #17 holding.
FourWorld Capital Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2024 and has held it in 9 quarters since.
115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on FourWorld Capital Management's 13F filing for Q1 2026, filed 15 May 2026.